[go: up one dir, main page]

PL2202307T5 - Sposób wytwarzania przeciwciała - Google Patents

Sposób wytwarzania przeciwciała

Info

Publication number
PL2202307T5
PL2202307T5 PL08838661T PL08838661T PL2202307T5 PL 2202307 T5 PL2202307 T5 PL 2202307T5 PL 08838661 T PL08838661 T PL 08838661T PL 08838661 T PL08838661 T PL 08838661T PL 2202307 T5 PL2202307 T5 PL 2202307T5
Authority
PL
Poland
Prior art keywords
antibody
production
Prior art date
Application number
PL08838661T
Other languages
English (en)
Other versions
PL2202307T3 (pl
Inventor
Yoshiki Yamada
Tatsuya Kiyasu
Kazuyuki Tabata
Akihiro Kuzumaki
Mai Yamashiro
Original Assignee
Chugai Seiyaku Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40567372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2202307(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Seiyaku Kabushiki Kaisha filed Critical Chugai Seiyaku Kabushiki Kaisha
Publication of PL2202307T3 publication Critical patent/PL2202307T3/pl
Publication of PL2202307T5 publication Critical patent/PL2202307T5/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
PL08838661T 2007-10-15 2008-10-14 Sposób wytwarzania przeciwciała PL2202307T5 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2007267384 2007-10-15
JP2008103308 2008-04-11
PCT/JP2008/068588 WO2009051108A1 (ja) 2007-10-15 2008-10-14 抗体の製造方法
EP08838661.0A EP2202307B2 (en) 2007-10-15 2008-10-14 Method for production of antibody

Publications (2)

Publication Number Publication Date
PL2202307T3 PL2202307T3 (pl) 2015-02-27
PL2202307T5 true PL2202307T5 (pl) 2021-10-04

Family

ID=40567372

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08838661T PL2202307T5 (pl) 2007-10-15 2008-10-14 Sposób wytwarzania przeciwciała

Country Status (17)

Country Link
US (3) US9683027B2 (pl)
EP (1) EP2202307B2 (pl)
JP (4) JP4976502B2 (pl)
KR (1) KR101558009B1 (pl)
CN (3) CN101802192A (pl)
AU (1) AU2008312937B2 (pl)
BR (1) BRPI0818674B1 (pl)
CA (1) CA2701338C (pl)
DK (1) DK2202307T4 (pl)
ES (1) ES2499391T5 (pl)
IL (2) IL205051A (pl)
MX (1) MX2010004007A (pl)
PL (1) PL2202307T5 (pl)
SG (1) SG185302A1 (pl)
SI (1) SI2202307T2 (pl)
TW (1) TWI463010B (pl)
WO (1) WO2009051108A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009051108A1 (ja) 2007-10-15 2009-04-23 Chugai Seiyaku Kabushiki Kaisha 抗体の製造方法
SI2493922T1 (sl) 2009-10-26 2017-06-30 F. Hoffmann-La Roche Ag Postopek za proizvodnjo glikoziliranega imunoglobulina
JP6001456B2 (ja) * 2010-12-28 2016-10-05 中外製薬株式会社 動物細胞の培養方法
BR112015022529A2 (pt) * 2013-03-15 2017-07-18 Genentech Inc meios de cultura de células e processos de produção de anticorpo
BR112015032960B1 (pt) 2013-07-04 2021-01-05 F. Hoffmann-La Roche Ag imunoensaio suprimido por interferência para detectar anticorpos anti-fármaco em amostras de soro
WO2018002036A1 (en) 2016-06-28 2018-01-04 Zaklady Farmaceutyczne Polpharma Sa Recombinant production of monoclonal antibodies
EP3541413A2 (en) 2016-11-21 2019-09-25 Polpharma Biologics S.A. Aqueous pharmaceutical formulations

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JPS6459878A (en) 1987-08-31 1989-03-07 Matsushita Electric Ind Co Ltd Semiconductor laser protective circuit
ES2139598T3 (es) 1990-07-10 2000-02-16 Medical Res Council Procedimientos para la produccion de miembros de parejas de union especifica.
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DE69127627T2 (de) 1990-08-29 1998-02-19 Genpharm Int Produktion und Nützung nicht-menschliche transgentiere zur Produktion heterologe Antikörper
EP0548267A4 (en) 1990-09-04 1994-11-23 Salk Inst Biotech Ind Production of insulin-like growth factor-1 in methylotrophic yeast cells
KR100249937B1 (ko) 1991-04-25 2000-04-01 나가야마 오사무 인간 인터루킨-6 수용체에 대한 재구성 인간 항체
CA2119930C (en) 1991-09-23 2002-10-01 Hendricus R. J. M. Hoogenboom Production of chimeric antibodies - a combinatorial approach
PT1024191E (pt) 1991-12-02 2008-12-22 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
CA2124967C (en) 1991-12-17 2008-04-08 Nils Lonberg Transgenic non-human animals capable of producing heterologous antibodies
EP0656941B1 (en) 1992-03-24 2005-06-01 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
JPH07509137A (ja) 1992-07-24 1995-10-12 セル ジェネシス,インク. 異種抗体の生産
CA2161351C (en) 1993-04-26 2010-12-21 Nils Lonberg Transgenic non-human animals capable of producing heterologous antibodies
GB9313509D0 (en) 1993-06-30 1993-08-11 Medical Res Council Chemisynthetic libraries
EP0731842A1 (en) 1993-12-03 1996-09-18 Medical Research Council Recombinant binding proteins and peptides
US5531053A (en) 1994-06-14 1996-07-02 Hamm; Hans Spring fastener for holding insulation against an inner surface of cavity walling
KR100261941B1 (ko) 1994-07-13 2000-07-15 나가야마 오사무 사람의 인터루킨-8에 대한 재구성 사람항체
US5561053A (en) 1994-08-05 1996-10-01 Genentech, Inc. Method for selecting high-expressing host cells
EP1978033A3 (en) 1995-04-27 2008-12-24 Amgen Fremont Inc. Human antibodies derived from immunized xenomice
CA2219486A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
JP2002514919A (ja) * 1997-04-04 2002-05-21 バイオサイト ダイアグノスティックス,インコーポレイテッド 多価ライブラリーおよびポリクローナルライブラリー
US20020062010A1 (en) 1997-05-02 2002-05-23 Genentech, Inc. Method for making multispecific antibodies having heteromultimeric and common components
JP4213224B2 (ja) 1997-05-02 2009-01-21 ジェネンテック,インコーポレーテッド ヘテロマルチマー及び共通成分を有する多重特異性抗体の製造方法
US6171586B1 (en) * 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
JP2005500018A (ja) 2001-04-02 2005-01-06 アイデック ファーマスーティカルズ コーポレイション GnTIIIと同時発現する組換え抗体
US6605176B2 (en) * 2001-07-13 2003-08-12 Taiwan Semiconductor Manufacturing Co., Ltd. Aperture for linear control of vacuum chamber pressure
US20030157641A1 (en) * 2001-11-16 2003-08-21 Idec Pharmaceuticals Corporation Polycistronic expression of antibodies
IL161988A0 (en) * 2001-11-16 2005-11-20 Corporation Idec Pharmaceutica Polycistronic expression of antibodies
ATE490787T1 (de) 2003-07-15 2010-12-15 Chugai Pharmaceutical Co Ltd Produktion von igm durch transformierte zellen und verfahren zur quantifizierung dieser igm- produktion
CA2559280A1 (en) * 2004-03-15 2005-09-29 Biogen Idec Ma Inc. Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
NZ579543A (en) 2004-07-09 2011-07-29 Chugai Pharmaceutical Co Ltd Anti-glypican 3 antibody
GB0425534D0 (en) * 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
EP2468881A3 (en) * 2005-07-21 2012-08-15 Abbott Laboratories Multiple gene expression including sorf contructs and methods with polyproteins, pro-proteins, and proteolysis
WO2009051108A1 (ja) * 2007-10-15 2009-04-23 Chugai Seiyaku Kabushiki Kaisha 抗体の製造方法

Also Published As

Publication number Publication date
IL240122A0 (en) 2015-09-24
IL205051A (en) 2015-09-24
US20100291627A1 (en) 2010-11-18
US11136375B2 (en) 2021-10-05
JP4976502B2 (ja) 2012-07-18
JP6092304B2 (ja) 2017-03-08
JP2012143246A (ja) 2012-08-02
BRPI0818674B1 (pt) 2023-01-17
JP5788830B2 (ja) 2015-10-07
KR20100074184A (ko) 2010-07-01
US12145978B2 (en) 2024-11-19
IL240122B (en) 2019-02-28
PL2202307T3 (pl) 2015-02-27
MX2010004007A (es) 2010-06-15
TWI463010B (zh) 2014-12-01
IL205051A0 (en) 2010-11-30
DK2202307T3 (da) 2014-09-15
SG185302A1 (en) 2012-11-29
BRPI0818674A2 (pt) 2014-10-14
ES2499391T5 (es) 2021-12-22
SI2202307T1 (sl) 2014-11-28
EP2202307B1 (en) 2014-08-20
US20170275351A1 (en) 2017-09-28
JPWO2009051108A1 (ja) 2011-03-03
EP2202307A1 (en) 2010-06-30
JP6506786B2 (ja) 2019-04-24
ES2499391T3 (es) 2014-09-29
TW200934867A (en) 2009-08-16
CN106244651A (zh) 2016-12-21
AU2008312937B2 (en) 2015-01-22
US9683027B2 (en) 2017-06-20
JP2015198663A (ja) 2015-11-12
KR101558009B1 (ko) 2015-10-19
JP2017079794A (ja) 2017-05-18
EP2202307A4 (en) 2012-01-25
WO2009051108A1 (ja) 2009-04-23
DK2202307T4 (da) 2021-10-04
CN101802192A (zh) 2010-08-11
SI2202307T2 (sl) 2021-11-30
CA2701338A1 (en) 2009-04-23
EP2202307B2 (en) 2021-07-14
CA2701338C (en) 2018-09-18
AU2008312937A1 (en) 2009-04-23
US20210300996A1 (en) 2021-09-30
CN103540632A (zh) 2014-01-29

Similar Documents

Publication Publication Date Title
HK1219741A1 (zh) 結構域抗體的生產方法
PL1903019T3 (pl) Sposób wytwarzania izoolefin
IL201082A0 (en) Bispecific antibodies and methods for production thereof
EP2157074A4 (en) PROCESS FOR THE PRODUCTION OF ACROLEINE
EP2061812A4 (en) METHOD FOR THE PRODUCTION OF ANTIBODIES
EP2135946A4 (en) METHOD FOR MANUFACTURING A POLYPEPTIDE
GB0711697D0 (en) Method of manufacture
EP2180052A4 (en) PROCESS FOR THE PRODUCTION OF L-LYSINE
IL197823A0 (en) Methods for improving antibody production
IL240122B (en) A method for producing an antibody
EP2192191A4 (en) PRODUCTION PROCESS FOR CAROTENOID
EP2233548A4 (en) PROCESS FOR PRODUCING FERROCOKE
EP2088136A4 (en) PROCESS FOR PRODUCING HYDROXYADAMANTANE-AMINE
EP2221384A4 (en) METHOD FOR MANUFACTURING ANTIBODY
SI2242628T1 (sl) Postopek izdelave betonskih cevi
PL2155679T3 (pl) Sposób wytwarzania pochodnych 4-formyloaminopiperydyny
EP2221294A4 (en) PROCESS FOR PREPARING N-CARBAMOYL-TERT.-LEUCIN
PL385356A1 (pl) Sposób wytwarzania tadalafilu
EP2211616A4 (en) PROCESS FOR PREPARING IMIDAZOAZEPINONE COMPOUNDS
EP1997812A4 (en) PROCESS FOR THE PREPARATION OF A CHINAZOLIN-4-ON DERIVATIVE
IL200230A0 (en) Method for the production of ??-ketonitriles
PL382168A1 (pl) Sposób wytwarzania S-(-)- 8-metoksy -2 tetralolu
HK1134925A1 (en) Method for the production of benzofuran-2-carboxamides
PL381401A1 (pl) Sposób wytwarzania o-etoksybenzamidu
GB0619764D0 (en) Method of producing antibodies